Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2000
03/29/2000EP0697891B1 Polyoxime compounds and their preparation
03/29/2000EP0611302B1 Receptors for treating late phase inflammatory responses
03/29/2000EP0596959B1 Self-adjuvanting peptide vaccine delivery system and production thereof
03/29/2000CN1249002A Component of bromelain
03/29/2000CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor
03/29/2000CN1248921A Methods of therapeutic administration of anti-CD40L compounds
03/29/2000CN1050840C 咪唑脂氧合酶抑制剂 Imidazole lipoxygenase inhibitors
03/28/2000US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof
03/28/2000US6043365 Reacting biaryl or carbocyclic or heterocyclic isopropyl nitrile derivative with a lower alkyl ester of formic acid, condensing the intermediate formed with an aminoalkyl ester to obtain intermediate, cyclizing and condensing
03/28/2000US6043280 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
03/28/2000US6043271 Method for the preparation of (±)-calanolide A and intermediates thereof
03/28/2000US6043263 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/28/2000US6043238 2-Aminobenzazapine derivatives
03/28/2000US6043085 Nucleotide and amino acid sequences; for treatment of infections/bactericides
03/28/2000US6043073 Phospholipase D polypeptide and DNA sequences
03/28/2000US6043069 Catalytic antibodies and a method of producing same
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6042832 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
03/28/2000CA2198084C Novel substituted piperidines useful for the treatment of allergic diseases
03/28/2000CA2126086C Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
03/28/2000CA2056662C Naphthoic acid derivative
03/28/2000CA1340935C Fc gamma receptor
03/26/2000CA2403011A1 Apparatus for electrical moxibustion using the extract
03/26/2000CA2283350A1 Method of preparing pharmaceutical artemisia extract and apparatus for electrical moxibustion using the extract
03/24/2000CA2283021A1 Substituted benzamides
03/23/2000WO2000015806A1 Atp synthase subunit homolog
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015788A2 Dna sequence encoding oncofetal ferritin protein
03/23/2000WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
03/23/2000WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015665A2 A method of producing a functional immunoglobulin superfamily protein
03/23/2000WO2000015639A1 Carboline derivatives as cgmp phosphodiesterase inhibitors
03/23/2000WO2000015614A1 Novel compounds
03/23/2000WO2000015609A1 Azetidine derivatives, preparation and medicines containing them
03/23/2000WO2000015264A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
03/23/2000WO2000015263A1 Expandible microparticle intracellular delivery system
03/23/2000WO2000015260A1 Anti-ige gene therapy
03/23/2000WO2000015257A1 Vaccine preparations containing saponins
03/23/2000WO2000015256A2 Immunostimulant emulsion
03/23/2000WO2000015252A1 Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner
03/23/2000WO2000015231A1 Adenosine a3 receptor modulators
03/23/2000WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
03/23/2000WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF
03/23/2000WO2000015198A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000WO2000002520A3 T-lymphocyte exchange
03/23/2000WO2000000599A3 Composition for the induction of apoptosis in target cells
03/23/2000WO1999061418A3 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
03/23/2000WO1996040039A3 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
03/23/2000DE19846979A1 New human and murine G-coupled receptor EDG (endothelial differentiation gene) 6, useful for modulating inflammatory and immune reactions and for treatment of allergy or tumors
03/23/2000DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease
03/23/2000DE19816732A1 Diagnostik und Therapie von Erkrankungen im Zusammenhang mit HHV-8-Infektionen Diagnosis and treatment of diseases associated with HHV-8 infection
03/23/2000CA2344441A1 Expandible microparticle intracellular delivery system
03/23/2000CA2344336A1 Vaccine preparations containing saponins
03/23/2000CA2343838A1 Atp synthase subunit homolog
03/23/2000CA2343760A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2343355A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
03/23/2000CA2343313A1 A method of producing a functional immunoglobulin superfamily protein
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342771A1 Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner
03/23/2000CA2342313A1 Immunostimulant emulsion
03/23/2000CA2341440A1 Novel compounds
03/23/2000CA2341155A1 Genes encoding for the human and murine death inducer-obliterator-1
03/22/2000EP0987265A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/22/2000EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/22/2000EP0987024A2 Immunosuppressive agents
03/22/2000EP0986646A1 Ubiquitin conjugation proteins
03/22/2000EP0986572A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
03/22/2000EP0986563A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo 3,2-d]pyrimidin-4-ones
03/22/2000EP0986544A1 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents
03/22/2000EP0986530A1 Indane compounds and their pharmaceutical use
03/22/2000EP0986399A1 Chelating immunostimulating complexes
03/22/2000EP0986381A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
03/22/2000EP0986375A2 Use of mkc-442 in combination with other antiviral agents
03/22/2000CN1050514C Antiallergic composition for ophthalmic or nasal use
03/21/2000US6040480 Preparing 2-(1,1,1-trifluoro-2-hydroxy-4-cyclopropyl-but-3-yn-2-yl),4-chloroaniline; cyclization; human immunodeficiency virus (hiv) reverse transcriptase inhibitor nontoxic maaterials; nonchromagraphic purification
03/21/2000US6040447 Reacting a halogenated amino pyrimidine compound with acid anhydride or acid halide to form an intermediate, transforming the 6-halo group of the intermediate to an amine by displacement with ammonia, cyclizing with a base
03/21/2000US6040444 Process for preparing furan nitrone compounds
03/21/2000US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
03/21/2000US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases
03/21/2000US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040145 Potentiation of the immune response
03/21/2000US6040133 D-enzyme compositions and methods of their use
03/21/2000US6039974 Drugs of multilayer tablets
03/21/2000US6039969 Immune response modifier compounds for treatment of TH2 mediated and related diseases
03/21/2000US6039948 Amino acid sequences with beta subunit of chorionic gonadotropin endogenous to mammals
03/21/2000US6039946 Extracorporeal affinity adsorption devices
03/21/2000CA2146097C 1h-indole-3-glyoxylamide spla2 inhibitors
03/21/2000CA2000468C Piperidinyl benzimidazoles
03/16/2000WO2000014262A2 Methylation of plasmid vectors
03/16/2000WO2000014257A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000WO2000014230A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/16/2000WO2000014217A2 G-motif oligonucleotides and uses thereof
03/16/2000WO2000014114A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants
03/16/2000WO2000014089A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014086A1 Chemokine receptor antagonists and methods of use therefor
1 ... 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 ... 1172